Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 118

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 118
---
that the Selling Shareholder may offer under this prospectus. The Selling Shareholder may sell some, all or none of its shares in this
offering. We do not know how long the Selling Shareholder will hold the shares before selling them, and we currently have no agreements,
arrangements or understandings with the Selling Shareholder regarding the sale of any of the shares.

Beneficial ownership is determined in accordance with Rule 13d-3(d)
promulgated by the SEC under the Exchange Act, and includes shares of common stock with respect to which the Selling Shareholder have
voting and investment power. The percentage of Ordinary Shares beneficially owned by the Selling Shareholder following the offering shown
in the table below is based on an aggregate of 25,617,408,922 Ordinary Shares outstanding as of April 1, 2025. Because the purchase price
of the Depositary Shares issuable under the Purchase Agreement is determined on each Fixed Purchase Date, with respect to a Fixed Purchase,
on the applicable VWAP Purchase Date, with respect to a VWAP Purchase, and on the applicable Additional VWAP Purchase Date, with respect
to an Additional VWAP Purchase, the number of shares that may actually be sold by us to the Selling Shareholder under the Purchase Agreement
may be fewer than the number of shares being offered by this prospectus. The fourth column assumes the sale of all of the shares offered
by the Selling Shareholder pursuant to this prospectus.

We may amend or supplement
this prospectus from time to time in the future to update or change the Selling Shareholder list and the securities that may be resold.

Please see the section titled
“Plan of Distribution” for further information regarding the Selling Shareholder’s method of distributing these
securities.

| 73 |

| Name of Selling Shareholder     |     | Number of Ordinary 
 Shares Owned Prior 
 to Offering (1)    |     | Maximum Number of        
 Ordinary Shares to       
 be Sold Pursuant to this 
 Prospectus               |                 |     | Number of          
 Ordinary           
 Shares Owned After 
 Offering (2)       |     | Percentage   
 of Ordinary  
 Shares Owned 
 after the    
 Offering (3) |
| C/M Capital Master Fund, LP (4) |     | --                 |     |                          | 341,352,000,000 |     | --                 |     | --           |

_____________

| (1) | In accordance with Rule 13d-3(d) under the Exchange